Swiss Biotech Insight Series 2019

Share this event

Clinical Trial Strategy:  Fine-tuning the Risk–Reward Profile


The event, organized by the Swiss Biotech Association in association with Parexel Switzerland, will take place on Thursday 19 September 2019 in Lausanne.



1PM – Registration and networking (refreshments will be provided)


1:30PM – Session 1: The fast lane to proof of concept
  1. From No to Yes: What are licensing partners looking for?
  2. The Fast Lane to Proof of Concept
  3. Clinical development strategies: lessons learnt and implications for the future
  4. Current challenges in oncology development


2:30PM – Break


3PM – Session 2: New drug development technologies
  1. Using Biomarkers to Improve the Quality of Decision Making in Drug Development
  2. Real World Data Science and the Future of Clinical Trial Design
  3. Adaptive Designs: Statistical, Operational and Regulatory Issues


4PM – Break


4:30PM – Session 3: New frontiers in pharma research & development
  1. New frontiers in Pharma R&D Investment: Sharing risks and rewards over product development cycle
  2. IPO on SIX: The leadership team also goes public
  3. The China opportunity: Considerations for clinical strategy


5:30PM – Cocktail



More information and registration